Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries. Histological analysis of liver tissue is the only widely accepted test for diagnosing and ...

The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...

Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries. Histological analysis of liver tissue is the only widely accepted test for diagnosing and ...

As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that ...

Metabolic dysfunction--associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affects 1.5% to 6.5% of all U.S. adults.

Researchers in California have developed an artificial liver tissue through 3D-printing that is capable of mimicking the structure and functions of the human liver. The team believes the new ...

In a bid to gain further understanding of the etiology and pathogenesis of metabolic dysfunction–associated steatohepatitis (MASH), a team of researchers has created 3D bioprinted liver models. MASH, ...

A new method of 3D printing an anatomically accurate replica of the human liver is now helping to guide surgeons during tricky procedures. The 3D-printed replicas, which are made of transparent ...

The Physicians Committee for Responsible Medicine, a nonprofit that advances human-based science, and InSphero, a global ...

A stained micrograph of 3D primary human liver cell tissue modeling MASH. Areas of fibrosis are indicated in blue. Image courtesy of Viscient Biosciences. Metabolic dysfunction- associated ...